1. GlaxoSmithKline Gains Key Supporters in Potential Proxy Battle

    GlaxoSmithKline Gains Key Supporters in Potential Proxy Battle

    GlaxoSmithKline PLC (NYSE:GSK) is shoring up its defenses as the giant British pharmaceutical company girds for a potential battle with a well-known activist investor. Fierce Pharma reported embattled CEO Emma Walmsley has enlisted the support of three large institutional investors in the company's proxy fight against Elliott Management...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. That's its modus operandi. It's in it for shareholder returns as fast as it can get
  3. Topics Mentioned